A doctor at the National Institutes of Health is warning patients against taking alj pills to treat alj.7.
It’s known to cause cancer and even a rare form of kidney cancer.
The FDA has not yet approved alj for that use.
Alj 7 is a herbal supplement made by Alj Al-Shihabi that is similar to other pills called alj and is often sold online.
It has a shelf life of four weeks.
Its effectiveness is measured in the amount of pain relief, muscle strength, and blood pressure you feel, but alj 7’s side effects can include: nausea, diarrhea, and stomach aches.
Some of the side effects listed include: dizziness, muscle cramps, vomiting, dizziness with rapid heart rate, muscle aches, and nausea.
Other side effects include: headaches, fatigue, and skin rash.
Alkalene, the active ingredient in alj7, is known to trigger liver damage and even liver tumors.
There are no known side effects when taken in moderation.
Dr. Peter W. Smith, a physician at the NIH who works at a facility that dispenses alj medicines, said he didn’t think alj was a good idea.
He said there were some patients that needed to be carefully watched for side effects, but he didn’ t want to encourage the use of the alj supplements.
Dr Smith said he also did not think there were enough studies to make a recommendation.
He cautioned patients against using alj to treat other conditions.
Aljamain said he did not believe the FDA would approve alj because it’s not a FDA approved drug.
He says the FDA is trying to protect people who want to use it, even though the agency does not have a scientific consensus about its use.
He also said the agency has been slow to approve the drug, which he says is a form of “medicine with no safety data whatsoever.”
Aljamains family has filed a class action lawsuit in New York State against the drug maker that made the pills.
He believes the drug is dangerous.
He told CBS News the drug could cause liver damage in people who use it to treat a disease, and it could cause kidney damage in someone who uses it to cure a disease.
“It’s a dangerous drug, it’s a very dangerous drug,” Aljamain told CBS’ “60 Minutes.”
“It’s like trying to put a dart in a cannon.”
Alj7 is being sold as an herbal supplement for alj patients.
Alistair Bowers, a spokesperson for the U.S. Food and Drug Administration, told CBS New York that the agency can’t comment on specific cases, but it does look into claims of safety and efficacy of new or used drugs.
Alj 7, she said, has been approved for use in some studies for treatment of cancer, liver, kidney, and prostate cancer.
The FDA has said it is working with other health agencies to make alj safer.